Alicia Morgans is a Genitourinary Medical Oncologist and the Medical Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported outcome measures, as well as incorporating patient preferences and beliefs into clinical decision making. Her research has investigated complications of systemic therapy for prostate cancer survivors, including the study of skeletal, cardiovascular, diabetic, and cognitive complications. Her work has been funded by grants from the Prostate Cancer Foundation and the Department of Defense.
Primary Specialty
Oncologist
GenderFemale
EducationUniversity of Pennsylvania, Perelman School of Medicine
ServicesDana-Farber Cancer Institute provides oncology services in Boston, MA. Oncology includes the diagnosis and treatment of breast cancer, skin cancer, prostate cancer, and many other forms of cancer.
Contact Alicia Morgans, MD, MPH at (877) 442-3324 for specific information about cancer treatment in Boston, MA.